Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

3 Key Facts From The Australian Pharmaceutical Industries Ltd (ASX:API) Report

Australian Pharmaceutical Industries Ltd (ASX: API) has reported its annual report for the year ended 31 August 2018.

Australian Pharmaceutical Industries is a pharmaceutical distribution, retailing and manufacturing business. It operates the Priceline chain of pharmacies around Australia.

3 Key Facts:

1: Total revenue decreased by 0.9% to $4.03 billion.

Management attributed a key part of the decline to a drop in demand for Hepatitis C medicines of around $155 million. Excluding that factor, revenue increased by 3.3% compared to the previous year.

2: Net profit after tax fell 8.2% to $48.2 million.

This figure includes the $4.1 million costs relating to the Clearskincare acquisition and $2.5 million relating to business restructuring to lower the ongoing cost base. Excluding these effects, underlying net profit grew by 0.8% to $54.7 million according to the company.

3: The final dividend was increased by 14.3%.

API declared a 4 cents per share fully franked dividend. This brought the company’s dividend payout ratio to 77%.

Outlook

The company is predicting that it will achieve earnings growth in FY19.

Managing Director Richard Vincent said: “While still only early in the year, retail trading in FY19 is in line with our internal expectations. We await the Christmas trading period and the outcome of the CSO review before providing further guidance.”

The Australian Pharmaceutical Industries share price has risen 8.8% over the past year according to Google Finance.

Podcast: Afterpay, Family and Investing

If you’re wanting to know more about Afterpay and how to become a better investor, this episode of Rask Group’s Australian Investors Podcast is a ‘must listen’ for serious investors. This episode provides unique insights from an Australian investor who’s keen on some ASX tech shares.

Tune in to The Australian Investors Podcast to hear from Australia’s leading investors and financial thinkers. Download the latest episode free on iTunes,  CastboxYouTube or wherever you choose to listen.

*As voted by us

itunessoundcloudcastboxdownload

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content